STRIATE+
LIVE

Serial Number

79308964

Owner

Orthocell Limited

Attorney

Matthew J. Stark

Filing Date

Feb 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STRIATE+ Trademark

Serial Number: 79308964 • Registration: 6624450

STRIATE+ is a trademark filed by Orthocell Limited on February 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Orthocell Limited (15 trademarks)

Building 191,

Entity Type: 99

Trademark Details

Filing Date

February 22, 2021

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Stem cells for medical purposes; collagen for medical use; surgical biodegradable implants being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implant materials being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implantable materials being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implants comprised of living tissues; therapeutic agents for tissue regeneration; therapeutic biological products namely biological cell cultures for medical purposes; medical preparations namely medical preparations for tissue regeneration; guided tissue regeneration materials namely materials for the regeneration of bone and soft tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone tissue; tissues for medical use being living cells; implantable collagen based scaffolding comprising biologically derived collagen for biomechanical support and stabilisation; cellular therapeutic tendon and cartilage regeneration products, namely, preparations comprising cells for the regeneration of bone and soft tissue

Advisory services relating to medical services; medical services; medical health assessment services; provision of medical information; therapy services being cellular therapy services for the regeneration of bone and soft tissue; physical therapy; medical services featuring biomechanical and cellular therapeutic medical techniques

Medical implants made of artificial materials; orthopaedic implants made of artificial materials; surgical implants comprised of artificial materials; dental implants; biodegradable bone fixation implants; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical implants comprised of artificial materials for replacing human tissue; surgical prostheses namely surgical prostheses for replacing bone and soft tissue; artificial skin for surgical purposes; surgical implants for use in human medicine in the nature of implants made of synthetic materials for use in the regeneration of bone and soft tissue; orthopaedic materials namely synthetic materials for use in the regeneration of bone and soft tissue; orthopaedic implants made of artificial materials; artificial materials for use in guided tissue regeneration namely implantable scaffolds comprising artificial materials for the regeneration of bone and tissue; artificial replacement materials for human tissue namely synthetic collagen based scaffolding materials; replacement materials for animal and human tissue namely synthetic collagen based materials

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 1, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 8, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 25, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2021 TROA
REFUSAL PROCESSED BY IB
Jun 7, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 17, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 17, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 14, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 13, 2021 CNRT
ASSIGNED TO EXAMINER
May 12, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 20, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 15, 2021 REPR